Market LIVE
Published markets; coverage varies by country
Product profile · United States

SUBSYS

 ·  Patent Litigation & Settlement History ↓

IngredientFENTANYL
Application typeNDA
Application202788
Product005
Dosage formSPRAY
RouteSUBLINGUAL
Strength0.8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval date2012-01-04
Marketing statusDiscontinued
Status event—
ApplicantBTCP PHARMA
Product source

Current GenericRadar decision

Year2022
SelectionDISCONTINUED
ReviewFINAL
Anchor typeDISCONTINUED
Anchor date—
Patent anchor—
Exclusivity anchor2015-01-04
Protection date—
First Final ANDA—
Status event—

GNR judgment: DISCONTINUED. Reference year: 2022. Anchor type: DISCONTINUED. Patent anchor: not recorded. Exclusivity anchor: 2015-01-04. Anchor date: not recorded. Patent tail: not established. Exclusivity tail: not established. Review status: FINAL. Historical detailed rationale is retained in the evidence snapshot; this is a structured English summary, not a literal translation.

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
100164032027-01-25DP ————
———
106105232027-01-25DP ————
———
88354602027-01-25DP/U U-55———
———
92419352027-01-25DP ————
———
92893872027-01-25DP/U U-55———
———
96427972027-01-25DP/U U-55———
———
96428442027-01-25DP ————
———
84869722030-04-27DP ————
———
84869732030-04-27U U-55———
———

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
No exclusivity facts are recorded in this product snapshot.

2026-10-10 · NO_RECORD_IN_CURRENT_SNAPSHOT · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
No generic approval facts are linked to this product.

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 0 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
No final-approval records are linked to this product.
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.